Loading...

FITC anti-mouse/human CD45R/B220 Antibody FITC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103205 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103206 500 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  2. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  3. Zaman R, et al. 2021. Immunity. :. PubMed
  4. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  5. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  6. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  7. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  8. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  9. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  10. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  11. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  12. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  13. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  14. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  15. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  16. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  17. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  18. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  19. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  20. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  21. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  22. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  23. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  24. Israelow B, et al. 2020. bioRxiv. . PubMed
  25. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  26. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  27. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  28. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  29. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  30. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  31. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  32. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  33. Dong L, et al. 2021. Cancer Cell. . PubMed
  34. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  35. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  36. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  37. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  38. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  39. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  40. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  41. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  42. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  43. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  44. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  45. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  46. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  47. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  48. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  49. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  50. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  51. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  52. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  53. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  54. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  55. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  56. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  57. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  58. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  59. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  60. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  61. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  62. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  63. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  64. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  65. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  66. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  67. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  68. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  69. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  70. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  71. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  72. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  73. Köchl R, et al. 2020. Elife. 9:00. PubMed
  74. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  75. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  76. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  77. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  78. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  79. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  80. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  81. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  82. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  83. Hutter K, et al. 2020. FEBS J. . PubMed
  84. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  85. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  86. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  87. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  88. Roy K, et al. 2019. Immunity. 50:616. PubMed
  89. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  90. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  91. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  92. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  93. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  94. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  95. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  96. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  97. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  98. Li H, et al. 2020. Nature. 584:274. PubMed
  99. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  100. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  101. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  102. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  103. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  104. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  105. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  106. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  107. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  108. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  109. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  110. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  111. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  112. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  113. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  114. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  115. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  116. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  117. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  118. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  119. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  120. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  121. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  122. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  123. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  124. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  125. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  126. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  127. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  128. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  129. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  130. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  131. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  132. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  133. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  134. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  135. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  136. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  137. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  138. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  139. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  140. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  141. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  142. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  143. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  144. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  145. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  146. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  147. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  148. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  149. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  150. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  151. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  152. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  153. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  154. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  155. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  156. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  157. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  158. Zaman R, et al. 2021. Immunity. :. PubMed
  159. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  160. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  161. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  162. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  163. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  164. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  165. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  166. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  167. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  168. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  169. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  170. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  171. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  172. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  173. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  174. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  175. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  176. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  177. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  178. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  179. Israelow B, et al. 2020. bioRxiv. . PubMed
  180. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  181. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  182. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  183. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  184. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  185. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  186. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  187. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  188. Dong L, et al. 2021. Cancer Cell. . PubMed
  189. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  190. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  191. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  192. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  193. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  194. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  195. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  196. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  197. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  198. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  199. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  200. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  201. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  202. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  203. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  204. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  205. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  206. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  207. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  208. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  209. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  210. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  211. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  212. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  213. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  214. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  215. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  216. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  217. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  218. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  219. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  220. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  221. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  222. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  223. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  224. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  225. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  226. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  227. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  228. Köchl R, et al. 2020. Elife. 9:00. PubMed
  229. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  230. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  231. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  232. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  233. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  234. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  235. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  236. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  237. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  238. Hutter K, et al. 2020. FEBS J. . PubMed
  239. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  240. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  241. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  242. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  243. Roy K, et al. 2019. Immunity. 50:616. PubMed
  244. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  245. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  246. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  247. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  248. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  249. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  250. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  251. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  252. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  253. Li H, et al. 2020. Nature. 584:274. PubMed
  254. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  255. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  256. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  257. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  258. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  259. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  260. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  261. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  262. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  263. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  264. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  265. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  266. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  267. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  268. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  269. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  270. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  271. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  272. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  273. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  274. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  275. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  276. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  277. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  278. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  279. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  280. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  281. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  282. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  283. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  284. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  285. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  286. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  287. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  288. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  289. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  290. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  291. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  292. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  293. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  294. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  295. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  296. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  297. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  298. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  299. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  300. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  301. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  302. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  303. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  304. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  305. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  306. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  307. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  308. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  309. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  310. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312991 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about PTPRC on UniProt.org

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Fire™ 780 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark YG™ 593 anti-mouse/human CD45R/B220 (Flexi-Fluor™) Antibody RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103205 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103206 500 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  2. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  3. Zaman R, et al. 2021. Immunity. :. PubMed
  4. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  5. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  6. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  7. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  8. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  9. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  10. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  11. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  12. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  13. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  14. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  15. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  16. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  17. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  18. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  19. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  20. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  21. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  22. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  23. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  24. Israelow B, et al. 2020. bioRxiv. . PubMed
  25. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  26. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  27. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  28. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  29. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  30. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  31. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  32. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  33. Dong L, et al. 2021. Cancer Cell. . PubMed
  34. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  35. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  36. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  37. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  38. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  39. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  40. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  41. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  42. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  43. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  44. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  45. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  46. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  47. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  48. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  49. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  50. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  51. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  52. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  53. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  54. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  55. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  56. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  57. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  58. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  59. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  60. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  61. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  62. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  63. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  64. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  65. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  66. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  67. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  68. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  69. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  70. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  71. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  72. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  73. Köchl R, et al. 2020. Elife. 9:00. PubMed
  74. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  75. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  76. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  77. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  78. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  79. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  80. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  81. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  82. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  83. Hutter K, et al. 2020. FEBS J. . PubMed
  84. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  85. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  86. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  87. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  88. Roy K, et al. 2019. Immunity. 50:616. PubMed
  89. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  90. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  91. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  92. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  93. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  94. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  95. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  96. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  97. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  98. Li H, et al. 2020. Nature. 584:274. PubMed
  99. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  100. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  101. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  102. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  103. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  104. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  105. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  106. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  107. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  108. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  109. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  110. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  111. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  112. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  113. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  114. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  115. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  116. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  117. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  118. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  119. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  120. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  121. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  122. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  123. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  124. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  125. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  126. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  127. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  128. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  129. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  130. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  131. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  132. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  133. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  134. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  135. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  136. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  137. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  138. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  139. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  140. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  141. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  142. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  143. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  144. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  145. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  146. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  147. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  148. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  149. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  150. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  151. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  152. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  153. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  154. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  155. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  156. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  157. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  158. Zaman R, et al. 2021. Immunity. :. PubMed
  159. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  160. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  161. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  162. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  163. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  164. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  165. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  166. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  167. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  168. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  169. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  170. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  171. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  172. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  173. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  174. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  175. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  176. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  177. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  178. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  179. Israelow B, et al. 2020. bioRxiv. . PubMed
  180. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  181. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  182. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  183. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  184. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  185. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  186. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  187. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  188. Dong L, et al. 2021. Cancer Cell. . PubMed
  189. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  190. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  191. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  192. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  193. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  194. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  195. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  196. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  197. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  198. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  199. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  200. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  201. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  202. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  203. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  204. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  205. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  206. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  207. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  208. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  209. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  210. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  211. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  212. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  213. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  214. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  215. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  216. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  217. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  218. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  219. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  220. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  221. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  222. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  223. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  224. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  225. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  226. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  227. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  228. Köchl R, et al. 2020. Elife. 9:00. PubMed
  229. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  230. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  231. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  232. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  233. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  234. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  235. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  236. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  237. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  238. Hutter K, et al. 2020. FEBS J. . PubMed
  239. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  240. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  241. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  242. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  243. Roy K, et al. 2019. Immunity. 50:616. PubMed
  244. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  245. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  246. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  247. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  248. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  249. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  250. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  251. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  252. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  253. Li H, et al. 2020. Nature. 584:274. PubMed
  254. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  255. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  256. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  257. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  258. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  259. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  260. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  261. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  262. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  263. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  264. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  265. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  266. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  267. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  268. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  269. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  270. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  271. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  272. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  273. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  274. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  275. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  276. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  277. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  278. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  279. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  280. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  281. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  282. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  283. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  284. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  285. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  286. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  287. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  288. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  289. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  290. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  291. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  292. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  293. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  294. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  295. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  296. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  297. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  298. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  299. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  300. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  301. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  302. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  303. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  304. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  305. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  306. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  307. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  308. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  309. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  310. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312991 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about PTPRC on UniProt.org

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Fire™ 780 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark YG™ 593 anti-mouse/human CD45R/B220 (Flexi-Fluor™) Antibody RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account